Article
The Clinical Role of miRNAs in the Development and Treatment of Glioblastoma
2025-02-04
Abstract excerpt
Glioblastoma multiforme (GBM) is the most common brain tumour and one of the most aggressive, with a median overall survival (OS) of only 15-18 months. These characteristics make it necessary to identify new targets for the improvement of prognosis and better prediction of response to therapies currently available for GBM patients. One possible candidate target could be the evaluation of miRNAs. miRNAs are small n...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 518445b7-d5fd-5a01-a698-028fea728cda
- DOI
- 10.20944/preprints202502.0177.v1
